Patient P-03013
Therapy response
Unstable
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
8%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 ONX-7 started — Baseline state S07
- Day 23 GI-04 recommended — GI Support Protocol GI-04
- Day 24 Patient accepted — Started GI-04 in the companion
- Day 32 GI symptom burden −18% vs expected — GI Support Protocol GI-04
- Day 36 Trajectory diverged from prediction — Observed response fell below the model's expected path.
- Day 38 Tolerance state changed — Unstable → Improving
What changed?
Trajectory began diverging from predicted response on Day 36.
Primary contributors, last 14 days
- Nutritional resilience+3
- Treatment adherence-3
What helped?
- GI Support Protocol GI-04Day 23Result: symptom burden −18%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Energy level
Daily log6.7/10
stable · +0.2 vs previous 14 d
Stress level
Daily log3.4/10
improving · -0.4 vs previous 14 d
Pessimism score
Daily log4.7/10
improving · -0.4 vs previous 14 d
Sleep quality
Wearable57/100
improving · +2.2 vs previous 14 d
Libido
Daily log5.3/10
stable · -0.1 vs previous 14 d
HRV
Wearable37.7 ms
stable · -0.6 vs previous 14 d
Toxicity
Blood14.8/100
worsening · +3.4 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 82 from the failing basin, 50 from restoration.
Good elements to keep
- GI Support Protocol GI-04intervention · steering +19.8
- Protein (supports)perturbation · steering +8.1
- Butyrate producers intacthidden · steering +7.5
- Histamine load (supports)perturbation · steering +3.8
- Proteinsupporter · GI -4.7 next day
- Histamine loadsupporter · GI -2.4 next day
Main detractors to watch
- Poor metabolizerhidden · steering -12.7
- Bacteroides fragilis elevatedhidden · steering -7.4
- Lactoseperturbation · steering -7.3
- Caffeineperturbation · steering -5.2
- Lactosedetractor · GI +4.1 next day
- Caffeinedetractor · GI +3.4 next day
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-4.7supporter · 95%
- Lactose+4.1detractor · 95%
- Caffeine+3.4detractor · 94%
- Histamine load-2.4supporter · 65%
- Alcohol+1.4no signal · 36%
- Dietary fat load-0.2no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Drug metabolism and exposure ↑40
- DNACYP2D6 poor metabolizer → higher exposure
- Inflammatory signalling ↓35
- MicrobiomeBacteroides fragilis expansion
- WearableHRV 38 ms, trending down
DNA
Fictional pharmacogenomic panel
- CYP2D6 Poor metabolizerHigher exposure at standard dose
Microbiome
Shannon diversity 3.1 · butyrate capacity 51/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 38 ms
- Sleep
- 7.2 h
- Steps
- 3,935
- Resting HR
- 68 bpm
Daily log: GI score 7, nutritional resilience 74, adherence 86.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-03426 | 43% | S18 | BR-03 | improved | 27 |
| P-03235 | 39% | S13 | GI-04 | improved | 29 |
| P-03373 | 36% | S17 | BR-03 | improved | 34 |
| P-03307 | 33% | S03 | ME-01 | improved | 17 |
| P-03380 | 33% | S16 | AD-05 | improved | 34 |
| P-03233 | 31% | S19 | DT-01 | improved | 47 |
| P-03277 | 30% | S14 | BR-03 | improved | 41 |
| P-03424 | 30% | S12 | AD-05 | improved | 41 |
| P-03215 | 29% | S16 | HY-01 | improved | 44 |
| P-03114 | 27% | S11 | DT-01 | improved | 48 |
| P-03143 | 27% | S11 | DT-01 | improved | 49 |
| P-03204 | 27% | S16 | AD-05 | improved | 48 |